Trade names Celontin Routes of
administration By mouth (capsules) Molar mass 203.237 g/mol | MedlinePlus a682028 ATC code N03AD03 (WHO) CAS ID 77-41-8 | |
 | ||
AHFS/Drugs.com Consumer Drug Information Pregnancy
category US: C (Risk not ruled out) | ||
Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland) and Celontin (United States). The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.
Medical use
is indicated for the control of absence seizures that are refractory to other drugs.
References
Mesuximide Wikipedia(Text) CC BY-SA